CD47抗体CD47一抗抗体Surface antigen
identified by monoclonal antibody 1D8 antibody抗体CD47 Antibody抗体- ￥880 - 1320
- CUSABIO
- CN
- CSB-PA005993
- 2025年07月12日
- WB, ELISA; WB:1:500-1:2000, ELISA:1:20000
- Rabbit
- Human
企业认证
相关产品推荐更多 >
SLC6A6抗体SLC6A6兔多抗抗体TAUT antibody抗体SLC6A6 Antibody, FITC conjugated抗体
￥880
CDH9抗体CDH9兔多抗抗体T1 cadherin antibody抗体CDH9 Antibody抗体
￥440
SETBP1抗体SETBP1兔多抗抗体Setbp1 antibody抗体SETBP1 Antibody, HRP conjugated抗体
￥880
ECH1抗体ECH1兔多抗抗体Peroxisomal enoyl coenzyme A hydratase like protein antibody抗体ECH1 Antibody抗体
￥440
ATP6V1A抗体ATP6V1A一抗抗体VPP2 antibody抗体ATP6V1A Antibody抗体
￥3900
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Synthesized peptide derived from the Internal region of Human CD47.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
/
- 标记物：
Non-conjugated
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q08722
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
WB, ELISA; WB:1:500-1:2000, ELISA:1:20000
- 浓度：
>95%,The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 靶点：
CD47
- 抗体英文名：
CD47 Antibody
- 抗体名：
Surface antigen identified by monoclonal antibody 1D8 antibody
- 规格：
100μg/50μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
保存缓冲液
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.功能
/风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Monoclonal Antibody Affinity Chromatography
with the desired properties. Once an appropriate monoclonal antibody has been identified, then in principle the purification of the corresponding antigen is straightforward and is limited in quantity only by the availability of the starting material.
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
双特异抗体(Bispecific antibody)的简介和制作方法
not served sufficiently by conventional therapies. The hallmark of monoclonal antibodies is their specific binding to a particular antigen, which enables them to find their target precisely in vivo while ignoring antigen-negative sites. Bound to a target
技术资料暂无技术资料 索取技术资料
